Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases

NCT06248606 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
NSCLC
KRAS G12C

Interventions

DRUG: Adagrasib
RADIATION: Stereotactic Radiosurgery

Sponsor

Ryan Gentzler, MD

Collaborators

[object Object]
[object Object]